Total Payments
$1,896
2024 Payments
$248.24
Companies
17
Transactions
70
Medicare Patients
2,500
Medicare Billing
$311,129
Payment Breakdown by Category
Food & Beverage$1,896 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,896 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $929.39 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $308.35 | 7 | $0 (2024) |
| AbbVie Inc. | $159.57 | 6 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $100.71 | 1 | $0 (2017) |
| Lilly USA, LLC | $62.95 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $47.77 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $41.82 | 2 | $0 (2022) |
| Amarin Pharma Inc. | $33.98 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.48 | 2 | $0 (2022) |
| PFIZER INC. | $31.75 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.24 | 8 | AstraZeneca Pharmaceuticals LP ($87.51) |
| 2023 | $363.17 | 12 | AbbVie Inc. ($140.30) |
| 2022 | $458.79 | 17 | Novo Nordisk Inc ($235.87) |
| 2021 | $514.47 | 19 | Novo Nordisk Inc ($463.09) |
| 2020 | $34.43 | 2 | Novo Nordisk Inc ($19.51) |
| 2019 | $85.25 | 5 | Novo Nordisk Inc ($50.32) |
| 2018 | $36.75 | 2 | Merck Sharp & Dohme Corporation ($18.39) |
| 2017 | $154.74 | 5 | Avanir Pharmaceuticals, Inc. ($100.71) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $87.51 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Inflammation | ||||||
| 01/31/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Medical Device | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 12/05/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 10/03/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: BH | ||||||
| 08/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/23/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Diabetes | ||||||
| 04/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $95.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Diabetes | ||||||
| 10/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.85 | General |
| 08/25/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 563 | 1,070 | $145,248 | $77,539 |
| 2022 | 7 | 619 | 1,134 | $142,918 | $82,208 |
| 2021 | 6 | 649 | 1,158 | $133,406 | $82,674 |
| 2020 | 8 | 669 | 1,194 | $133,207 | $68,709 |
Total Patients
2,500
Total Services
4,556
Medicare Billing
$311,129
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 642 | $84,054 | $38,621 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $28,934 | $20,514 | 70.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 175 | 226 | $26,505 | $15,542 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 28 | $5,043 | $2,668 | 52.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $711.96 | $194.72 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 641 | $81,150 | $39,847 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 151 | 151 | $27,211 | $20,682 | 76.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 182 | 250 | $29,003 | $17,904 | 61.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,580 | $1,938 | 75.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 14 | $1,603 | $907.80 | 56.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 53 | 53 | $768.50 | $762.75 | 99.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 14 | $603.08 | $166.23 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 193 | 684 | $84,382 | $43,738 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 138 | 138 | $22,687 | $19,557 | 86.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 150 | 166 | $18,947 | $13,906 | 73.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 14 | $4,370 | $3,287 | 75.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 132 | 132 | $1,914 | $1,902 | 99.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 23 | 24 | $1,106 | $283.38 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 188 | 631 | $72,594 | $32,084 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 128 | 128 | $21,043 | $15,784 | 75.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 171 | 243 | $27,719 | $13,156 | 47.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 12 | 16 | $4,994 | $3,208 | 64.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 20 | $2,935 | $1,857 | 63.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 98 | 98 | $1,421 | $1,409 | 99.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 29 | $1,164 | $813.20 | 69.9% |
About Dr. Russell Tom, M.D
Dr. Russell Tom, M.D is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346258407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Tom, M.D has received a total of $1,896 in payments from pharmaceutical and medical device companies, with $248.24 received in 2024. These payments were reported across 70 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,896).
As a Medicare-enrolled provider, Tom has provided services to 2,500 Medicare beneficiaries, totaling 4,556 services with total Medicare billing of $311,129. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 08/04/2006
- Last Updated 07/10/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346258407
Products in Payments
- Ozempic (Drug) $325.80
- RYBELSUS (Drug) $233.85
- FARXIGA (Drug) $220.84
- Rybelsus (Drug) $214.41
- NUEDEXTA (Drug) $100.71
- AIRSUPRA (Drug) $87.51
- DALVANCE (Drug) $49.72
- XARELTO (Drug) $47.77
- UBRELVY (Drug) $47.73
- Wegovy (Drug) $46.04
- NURTEC ODT (Drug) $41.82
- Saxenda (Drug) $37.53
- Vascepa (Drug) $33.98
- RINVOQ (Biological) $32.79
- ELIQUIS (Drug) $31.75
- Victoza (Drug) $29.60
- QULIPTA (Drug) $29.33
- ENTRESTO (Drug) $25.86
- PERSERIS (Drug) $25.03
- MOUNJARO (Drug) $23.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Internal Medicine $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Internal Medicine $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Internal Medicine $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Internal Medicine $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761
Internal Medicine $13,761